10
Aug 2026
A new study led by researchers at the University of Pittsburgh found that women living in socially vulnerable communities face a 20% higher risk of death after an ovarian cancer diagnosis compared with women living in less vulnerable communities.
10
Aug 2026
The recent advancement of miniaturized and portable electronics, particularly wearable and flexible devices, has increased the demand for self-powered sensing technologies.
10
Aug 2026
The brain evidently can regenerate itself better than previously assumed after injuries or certain autoimmune diseases.
10
Aug 2026
A joint research team led by Professor Sungsu Park of Sungkyunkwan University and Professor Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact with cancer cells can critically influence the therapeutic response in glioblastoma.
10
Aug 2026
More people with disabilities were actively looking for work in July compared to June, while the number of people without disabilities seeking employment declined over the same period.
10
Aug 2026
A small outbreak of a rare hantavirus on a cruise ship earlier this year captured worldwide attention and sparked concerns about a possible new pandemic.
10
Aug 2026
Researchers have uncovered a previously unknown mechanism that helps aging cells drive the chronic inflammation linked to many age-related diseases.
10
Aug 2026
Spinal cord injury begins with immediate mechanical damage, but much of the lasting neurological loss develops during the secondary phase, when inflammation, oxidative stress and disrupted metabolism continue to injure surviving tissue.
10
Aug 2026
Cochlear implants have transformed what is possible for people with profound hearing loss. But the next major advance may depend less on the device itself than on the brain's ability to learn how to use it.
10
Aug 2026
LUAD is the most common histological subtype of lung cancer. Although surgery can be curative for patients diagnosed at an early stage, approximately 30%-50% develop recurrence or aggressive metastasis within five years.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
